Valuation: Paion AG

Market Cap 144K 161K 133K 120K 224K 15.28M 229K 1.58M 635K 8.04M 604K 591K 25.34M P/E 2021
-3.89x
P/E 2022 -53x
Enterprise Value 9.87M 11.02M 9.08M 8.22M 15.37M 1.05B 15.66M 108M 43.45M 550M 41.35M 40.47M 1.74B EV / Sales 2021
14.1x
EV / Sales 2022 1.22x
Free-Float
100%
Yield 2021 *
-
Yield 2022 -
3 months-16.36%
6 months+3.37%
Current year+248.48%
1 week 0.05
Extreme 0.046
0.05
1 month 0.05
Extreme 0.046
0.06
Current year 0.01
Extreme 0.012
0.23
1 year 0.01
Extreme 0.012
0.23
3 years 0
Extreme 0.0001
0.36
5 years 0
Extreme 0.0001
18.34
10 years 0
Extreme 0.0001
36.78
Manager TitleAgeSince
Chief Executive Officer 62 2023-08-31
Director of Finance/CFO - 2022-05-31
Director TitleAgeSince
Director/Board Member 65 2012-09-30
Director/Board Member 75 2017-05-31
Director/Board Member - 2019-05-21
Date Insider Type Main position Quantity % Market Cap. Importance
12/27/22 Buy

Director

1,121 0.0016%
1/12/21 Buy

Chief Executive Officer

8,500 0.0127%
6/8/20 Buy

Chief Executive Officer

13,158 0.0202%
Change 5-day change 1-year change 3-year change Capi.($)
+32.61%0.00%+198.70%-86.49% 366K
-0.62%+0.50%+33.92%+60.07% 64.38B
+0.35%+3.20%+14.92%+84.55% 56.16B
+0.53%+1.96%+15.37%+106.81% 54.16B
-3.46%-5.20%+22.34%+49.49% 45.33B
-0.62%-2.33%+19.67%+97.65% 42.25B
-0.61%+1.03%+220.89%+929.48% 40.78B
+3.27%+47.96%+112.67%+96.48% 33.8B
+1.22%-1.39%+13.92%+46.95% 32.25B
-1.29%-1.72%+21.00%-6.85% 23.57B
Average -0.15%+4.25%+67.34%+137.81% 39.27B
Weighted average by Cap. -0.24%+3.64%+49.55%+161.17%

Financials

2021 2022
Net sales 7.13M 7.96M 6.56M 5.94M 11.11M 756M 11.31M 78.19M 31.39M 398M 29.87M 29.24M 1.25B 33.25M 37.12M 30.58M 27.71M 51.8M 3.52B 52.77M 365M 146M 1.85B 139M 136M 5.85B
Net income -21.79M -24.33M -20.04M -18.16M -33.94M -2.31B -34.58M -239M -95.93M -1.21B -91.29M -89.35M -3.83B -579K -646K -533K -483K -902K -61.39M -919K -6.35M -2.55M -32.29M -2.43M -2.37M -102M
Net Debt 13.77M 15.37M 12.67M 11.48M 21.45M 1.46B 21.85M 151M 60.63M 768M 57.7M 56.47M 2.42B 9.72M 10.86M 8.94M 8.1M 15.15M 1.03B 15.43M 107M 42.81M 542M 40.74M 39.88M 1.71B
Logo Paion AG
Paion AG is a Germany-based biopharmaceutical company. The Company's main product is remimazolam, an intravenous ultra-short-acting benzodiazepine sedative and anesthetic. In the human body, remimazolam is metabolized to an inactive metabolite by tissue esterase and not metabolized by cytochrome-dependent hepatic pathways. In addition to that, remimazolam, which is in Phase III clinical development, can be reversed with flumazenil to terminate sedation and anesthesia, if necessary. The product can be used for general anesthesia in Europe and procedural sedation in the United States. The Company operates sites in Aachen, Germany, Cambridge, the United Kingdom, and New Jersey, the United States.
Employees
64
Date Price Change Volume
26-10-28 €0.0460 0.00% 0
26-10-28 €0.0460 0.00% 0
26-10-27 €0.0460 0.00% 0
26-10-26 €0.0460 0.00% 0
26-10-23 €0.0460 0.00% 0
  1. Stock Market
  2. Stocks
  3. PA8K Stock